Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Chemotherapy|April 1, 2015
French Nationwide Cohort Temporary Utilization Authorization Survey of GranuPAS(®) in MDR-TB patientsYves Kibleur, Nicolas VezirisPaediatric Drugs|January 10, 2016
Long-Term Follow-Up on a Cohort Temporary Utilization Authorization (ATU) Survey of Patients Treated with Pheburane (Sodium Phenylbutyrate) Taste-Masked GranulesYves Kibleur, Nathalie GuffonClinical Therapeutics|January 4, 2011
Efficacy and tolerability of enteral formulations of ibuprofen in the treatment of patent ductus arteriosus in preterm infantsJean-Bernard Gouyon, Yves KibleurPaediatric Drugs|June 26, 2014
Results from a Nationwide Cohort Temporary Utilization Authorization (ATU) survey of patients in france treated with Pheburane(®) (Sodium Phenylbutyrate) taste-masked granulesYves Kibleur, Dries Dobbelaere, Magalie Barth, et al.Archives of Disease in Childhood|September 4, 2012
Developing a new formulation of sodium phenylbutyrateNathalie Guffon, Yves Kibleur, William Copalu, et al.Journal of Clinical Pharmacology|September 18, 2008
Population pharmacokinetic analysis of Ibuprofen enantiomers in preterm newborn infantsNicolas Gregoire, Luc Desfrere, Jean-Christophe Roze, et al.The Journal of Pediatrics|August 31, 2011
Unbound bilirubin does not increase during ibuprofen treatment of patent ductus arteriosus in preterm infantsLuc Desfrere, Celine Thibaut, Yves Kibleur, et al.Clinical Drug Investigation|February 4, 2014
Dose regimen of para-aminosalicylic acid gastro-resistant formulation (PAS-GR) in multidrug-resistant tuberculosisYves Kibleur, Hervé Brochart, Hendrik S Schaaf, et al.Pageof 1